CzMA JEP Home page CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ
Journals - Article
CzMA JEP Home page News About Assocation Publishing Division Medical Journals Searching Supplements Catalogue
 
  Česky / Czech version Čs. Pediat., 57, 2002, No. 4, p. 172-173
 
Treatment of Life Threatening Haemorrhage in Infant with Haemangiomatosis and with Manifestations of the Kassabach-Merrit Syndrome by Activated Recombinant Factor VII (rFVIIa) 
Blatný J., Magnová O., Štěrba J. 

Oddělení dětské onkologie, FN Brno - Dětská nemocnice, primář MUDr. J. Štěrba, PhD.
 


Summary:

       Recombinant Factor VIIa (rFVIIa) was successfully used to avert life-threatening bleeding in an infant with retroperitoneal haemangiomatosis and Kassabach-Merrit Syndrome. The use of rFVIIa in this patient was life-saving and enabled multimodal treatment of haemangiomatosis with chemotherapy and radiotherapy. This clinical experience thus contributes to the idea of further studies of rFVIIa as a haemostatic agent.

        Key words: Reombinant Factor VIIa, rFVIIa, haemangiomatosis, Kassabach-Merrit Syndrome
       

Order this issue

  BACK TO CONTENTS  
 
 
| HOME PAGE | CODE PAGE | CZECH VERSION |
©  1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o.
WEBMASTER